Global Health Priorities: Key Outcomes from the 79th World Health Assembly

The 79th World Health Assembly has concluded with a series of landmark decisions aimed at addressing some of the most persistent challenges in global public health. From infectious diseases to the rising burden of noncommunicable conditions and the critical need to combat health misinformation, member states have set a new agenda to improve health equity and outcomes by 2030 and beyond.

A New Roadmap for Tuberculosis Eradication

Despite significant progress over the last two decades—including the estimated saving of 83 million lives between 2000 and 2024—tuberculosis (TB) remains a leading infectious killer. Recognizing that global targets are currently off track due to factors such as underfunding, climate-related displacement, and conflict, the Assembly has officially requested the development of a post-2030 TB strategy.

This new framework will be developed under the coordination of the WHO Director-General and is slated for presentation at the 81st World Health Assembly in 2028. The strategy is designed to:

• Integrate emerging scientific advancements into current TB response efforts.
• Align TB programming with primary healthcare and universal health coverage agendas.
• Prepare the global community for the 2028 United Nations High-Level Meeting on TB.

Addressing the Rise of Steatotic Liver Disease

Delegates also turned their attention to the growing burden of noncommunicable diseases (NCDs) by passing a resolution on steatotic liver disease (SLD). Affecting approximately 1.7 billion people globally, this condition—formerly known as fatty liver disease—is increasingly linked to obesity, type 2 diabetes, and cardiovascular disease.

The resolution urges member states to incorporate SLD management into their national NCD strategies. By strengthening primary healthcare and promoting healthier diets and physical activity, health systems aim to prevent the progression of SLD toward more severe outcomes like cirrhosis and liver cancer.

Improving Care for Bleeding Disorders

In a significant win for patient equity, the Assembly endorsed a resolution to improve the diagnosis and treatment of haemophilia and other rare bleeding disorders. With an estimated 70% of people living with haemophilia currently undiagnosed, the resolution calls for:

• Integrating bleeding disorder management into primary health and maternal health policies.
• Improving access to life-saving therapies, including factor concentrates.
• Reducing the stigma surrounding these conditions through better data collection and public awareness.

Combating Health Misinformation

A strategic roundtable at the Assembly highlighted a growing consensus: health misinformation is a public health threat that undermines the efficacy of medical interventions. Leaders from the scientific community, government, and civil society emphasized that this is not merely a communication issue but a barrier to effective healthcare delivery.

Moving forward, the focus will shift toward proactive engagement rather than reactive corrections. This includes empowering health workers as trusted voices and collaborating with technology platforms to ensure that credible, evidence-based information reaches the public.

Key Takeaways

• Long-term Planning: A post-2030 TB strategy is in development to sustain momentum after the current Sustainable Development Goals deadline.
• NCD Focus: Steatotic liver disease is now formally recognized as a global health priority, necessitating integrated national responses.
• Equity in Care: New commitments aim to close the diagnostic gap for people living with haemophilia and other bleeding disorders.
• Information Integrity: Global leaders are prioritizing the protection of information ecosystems to rebuild trust in medical science.

These resolutions represent a collective effort to address both long-standing health disparities and emerging threats. As nations begin to implement these mandates, the focus remains on resilient health systems and the delivery of equitable care for all populations.